Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Toulouse
Clinical trial register · France

Clinical Trials in Toulouse, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 46 Marseille 37 Toulouse 32 Bordeaux 29 Lille 23
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Toulouse170 AstraZeneca32 Merck Sharp & Dohme LLC32 Novartis Pharmaceuticals30 AbbVie26 Clear sponsor filter
Site location
Paris46 Marseille37 Toulouse32 Bordeaux29 Lille23
All 72 locations
Target enrolment
to

Trials with a site in Toulouse

32 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Nice, Marseille, Toulouse, Angers, Le Mans, Saint Priest En Jarez, Villejuif
2026-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
450
Strasbourg, Toulouse, Villejuif
2026-03-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Lyon, Strasbourg, Marseille, Plérin, Brest, Toulouse, Limoges, Tours
2026-02-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Strasbourg, Brest, Caen, Chambray-lès-Tours, Bordeaux, Toulouse, Paris
2026-01-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
570
Bordeaux, Toulouse, Nantes, Lyon, Bobigny, Paris
2025-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
140
Strasbourg, Toulouse, Rennes, Vandœuvre-lès-Nancy, Villejuif
2025-07-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Nice, Caen, Toulouse, Limoges, Vandœuvre-lès-Nancy, Reims, Angers, Rouen
2025-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Marseille, Caen, Plérin, Bordeaux, Toulouse, Saint-Cloud, Saint-Herblain, Lyon
2025-05-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Lille, Bordeaux, Pierre-Bénite, Caen, Plérin, Toulouse, Chambray-lès-Tours, Paris
2025-04-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Bordeaux, Lyon Cedex08, Clermont-Ferrand, Strasbourg, Marseille, Plérin, Besançon, Toulouse
2024-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Nice, Pessac, Marseille, Toulouse, Limoges, Tours, Nantes, Pierre-Bénite
2024-07-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
473
Bordeaux, Lyon, Caen, Toulouse, Lille, Rennes, Poitiers, Paris
2024-05-03
Active, closed
Merck Sharp & Dohme LLC
Phase 2
272
Lyon Cedex08, Besançon, Toulouse, Paris, Villejuif
2024-04-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Brest, Toulouse, Rouen, Limoges, Valenciennes, Clermont-Ferrand, Bron, Toulon
2024-04-03
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Toulouse, Angers, Lille, Paris, Villejuif
2024-03-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Bordeaux, Lyon Cedex08, Chambray-lès-Tours, Plérin, Besançon, Toulouse, Lille, Montpellier
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
390
Bordeaux, Dijon, Toulouse, Pierre-Bénite, Paris
2023-06-23
Recruiting
Merck Sharp & Dohme LLC
Phase 2
42
Toulouse, Marseille, Paris
2023-01-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Marseille, Toulouse, Limoges
2022-03-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Nice, Dijon, Bordeaux, Toulouse, Rouen, Montpellier, Nantes, Tourcoing
2021-09-15
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Marseille, Dijon, Toulouse, Lille, Poitiers, Paris
2021-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Lyon, Marseille, Caen, Besançon, Toulouse, Montpellier, Saint-Herblain, Angers
2021-06-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Nice, Pessac, Strasbourg, Brest, Toulouse, Lille, La Tronche, Saint-Herblain
2021-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Marseille, Besançon, Brest, Toulouse, Limoges, La Tronche, Orléans, Lille
2021-04-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Marseille, Besançon, Toulouse, Limoges, Beuvry, Angers, Pierre-Bénite, Paris
2021-04-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Reims, Nice, Strasbourg, Bordeaux, Toulouse, Limoges, Saint-Herblain, Angers
2021-02-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Vandœuvre-lès-Nancy, Nice, Caen, Plérin, Besançon, Bordeaux, Toulouse, Montpellier
2021-01-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Marseille, Dijon, Caen, Besançon, Nîmes, Bordeaux, Toulouse, Montpellier
2019-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Caen, Dijon, Toulouse, Lille, Saint-Cloud, Montpellier, Metz, Avignon
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Nice, Marseille, Toulouse, Villejuif, Avignon, Paris
2018-12-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Marseille, Dijon, Bordeaux, Toulouse, Boulogne-Billancourt, Montpellier, Rennes, Angers
2018-09-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Suresnes, Pierre-Bénite, Strasbourg, Toulouse, Limoges, Chambéry, Pringy, Rouen
2018-04-24
Rows per page Showing 1–32 of 32
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/toulouse

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 32 of those studies with a site in Toulouse that also match the filters currently applied.

How many clinical trials are recruiting in Toulouse?

11 of the 32 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 21 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Toulouse), 32 studies
PhaseStudiesRecruitingShare
Phase 325878.1%
Phase 1/2319.4%
Phase 2319.4%
Phase 2/3113.1%

Most active sponsors

Lead sponsors with the most studies (Toulouse)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC3211
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.